Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
attenuated live hepatitis A vaccine (1 trial)
dihydroartemisinin (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
piperaquine (1 trial)
Malaria (Phase 3)
Trials (2 total)
Trial APIs (4 total)